-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $568

Benzinga·11/16/2026 12:01:16
Baird analyst Joel Beatty maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $514 to $568.